Log in
Research report
德邦证券-生物医药行业中特估系列专题(中药行业)：乘国企改革东风，中药中特估主线价值凸显-230608
邮箱： 姓名：张俊资格编号：S0120522080001邮箱： 乘国企改革东风，中药中特估主线价值凸显 核心逻辑： □中药+中特估表现亮眼：1）强政策支持下中药板块表现亮眼：自22年3月《“十四五”中医药发展规划》出台后，中药利好政策不断，中医药有望持续受政策催化并体现在上市公司收入与利润增速上；2）中药上市国企价值远超民营企业：A股上市中药企业共74家，其中国企数量占比22.97%，国企总市值和
Read full report →Related industries
No related institutions
Similar reports
- Knowing When to Stop: The Art of Making a Loop Converge
- Work-Study Programs Improve Young Women's Long-Term Labor Market Outcomes
- Sahel and West Africa Coastal Countries (SAWAC) Umbrella Program: 2026 Communications and Visibility Plan
- Scaling What Works: Integrated Social Protection Reforms for Poverty Reduction and Upward Mobility in Ghana